Glucagon-Like Peptide-1 Receptor Agonists—How Safe Are They?

A 64-year-old patient with Long-standing type 2 diabetes and a history of myocardial infarction expressed frustration with his elevated blood glucose level and inability to lose weight. He was taking metformin but wondered if he needed another medication. We discussed treatment options and he became...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Archives of internal medicine (1960) 2022-05, Vol.182 (5), p.520-521
Hauptverfasser:	Haider, Shanzay, Lipska, Kasia J
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiovascular disease Diabetes Diabetes Mellitus, Type 2 - drug therapy Disease management Glucagon-Like Peptide-1 Receptor Glucose Humans Hypoglycemic Agents - adverse effects Insulin Liraglutide - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!